Distinguished in Attention Deficit Hyperactivity Disorder (ADHD)

Ralf W. Dittmann

Mannheim, BW, DE 
Distinguished in Attention Deficit Hyperactivity Disorder (ADHD)
Mannheim, BW, DE 
OverviewLocationsClinical Research

Overview

Ralf Dittmann practices in Mannheim, Germany. Mr. Dittmann is rated as a Distinguished expert by MediFind in the treatment of Attention Deficit Hyperactivity Disorder (ADHD). His top areas of expertise are Attention Deficit Hyperactivity Disorder (ADHD), Restless Legs Syndrome, Obsessive-Compulsive Disorder (OCD), and Autism Spectrum Disorder.

His clinical research consists of co-authoring 70 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 40 articles and participated in 1 clinical trial in the study of Attention Deficit Hyperactivity Disorder (ADHD).

Gender
Male

Locations

Mannheim, BW, Germany
Other Locations
Aachen, NW 52056, Germany
Jena, TH, Germany
Juelich, NW, Germany
Heidelberg, BW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 3b, Double-blind, Randomised, Active-controlled, Parallel Group Study to Assess the Time to Response of Lisdexamfetamine Dimesylate to Atomoxetine Hydrochloride in Children and Adolescents Aged 6-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD) Who Have Had an Inadequate Response to Methylphenidate Therapy
A Phase 3b, Double-blind, Randomised, Active-controlled, Parallel Group Study to Assess the Time to Response of Lisdexamfetamine Dimesylate to Atomoxetine Hydrochloride in Children and Adolescents Aged 6-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD) Who Have Had an Inadequate Response to Methylphenidate Therapy
Enrollment Status: Completed
Publish Date: June 11, 2021
Intervention Type: Drug
Study Phase: Phase 3

70 Total Publications

Chemical termination and interfacial redox behavior of freestanding SrTiO3.
Chemical termination and interfacial redox behavior of freestanding SrTiO3.
Journal: Scientific reports
Published: March 06, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Dittmann's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile